Impaired salivary function with resultant severe dryness of the mouth,
or xerostomia, may occur in association with a variety of systemic di
sorders or therapies. No adequate treatment exists for this debilitati
ng condition, which impedes normal oral function, in particular alimen
tation and phonation. This study explores the feasibility of salivary
gland autotransplantation, using a canine model. A salivary gland with
its duct and surrounding blood vessels still attached was excised and
reimplanted in the dog's thigh by anastomosing the graft's blood vess
els to the femoral artery and vein. The duct was sutured to an artific
ial orifice cut in the thigh's skin, from which the saliva was collect
ed. Salivary secretion was induced by a single intravenous bolus of pi
locarpine (5 mg). Preoperative (normal) salivation was measured by col
lecting saliva from the gland in situ. Periodic functional studies sho
wed normal saliva production during the first month after grafting, af
ter which the salivary flow was reduced by 35% over the next 2 months.
This reduction was interpreted as a sign of disuse atrophy resulting
from the lack of autonomic innervation. To overcome this impediment, o
ral pilocarpine (5 mg/day) was administered to the recipient dog, afte
r which normal levels of saliva were excreted through the graft during
the 3-month follow-up period. The quality of the graft saliva was ass
essed by its protein and electrolyte levels, which showed close to nor
mal values.